HemosiderosisSymptoms, Doctors, Treatments, Advances & More
Learn About Hemosiderosis
- Hemosiderosis
Texas Health Family Care
William Drake is a primary care provider, practicing in Family Medicine in Fort Worth, Texas. Dr. Drake is rated as an Advanced provider by MediFind in the treatment of Hemosiderosis. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and High Cholesterol. Dr. Drake is currently accepting new patients.
Dudley Pennell practices practicing medicine in London, United Kingdom. Mr. Pennell is rated as an Elite expert by MediFind in the treatment of Hemosiderosis. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Hemosiderosis, Dilated Cardiomyopathy (DCM), Cardiomyopathy, Heart Transplant, and Heart Bypass Surgery.
UCSF Benioff Children's Hospital Oakland
Elliott Vichinsky is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Vichinsky is rated as an Elite provider by MediFind in the treatment of Hemosiderosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.
Summary: This single-center, non interventional cohort study investigates whether chronic iron overload influences the incidence of liver complications in adults who are at least 10 years beyond allogeneic hematopoietic stem cell transplantation (allo HSCT). Approximately 400-500 survivors transplanted at Hôpital Saint Louis between January 2004 and December 2014 will be evaluated. Transplant characteristi...
Summary: The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center